Why InspireMD More Than Doubled
Shares of InspireMD more than doubled in Tuesday’s session after the company announced followup data from its Paradigm-101 trial of the CGuard Embolic Prevention System.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 189
Organovo Makes Handy Gain on Positive Consumer Response
Organovo Holdings shares saw a handy gain on Tuesday after the bio-printer announced that it received a strong consumer response from its ExVive Human Kidney Tissue service.
Why Pfizer Earnings Did Not Live Up to Expectations
As Pfizer is a major player in the pharmaceutical industry, this earnings report is important in setting a direction that other companies can rally behind.
Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
Ophthotech Rises on Positive Mid-Stage Results
Ophthotech Corp. (NASDAQ: OPHT) is watching its shares rise in Monday’s trading session after the company reported results from its mid-stage trial of Fovista in combination with Lucentis for the treatment of wet age-related…
What to Expect From Pfizer Earnings
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Ariad Pharma Rises on FDA Decision
Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.
Genocea Biosciences Rises on Positive Herpes Trial Results
Genocea Biosciences shares saw a handy gain early Friday following the release of mid-stage results from its genital herpes treatment.
Is This the Beginning of the End of Opexa?
Opexa Therapeutics Inc. (NASDAQ: OPXA) shares were in free fall Friday morning after the company reported results from its mid-stage trial for the treatment of secondary progressive multiple sclerosis. The company said that its…
AbbVie Slides on Top-Line Miss
AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.
Amgen Sinks Despite Beating Street Estimates
Though Amgen reported better-than-expected third-quarter results on Thursday, shares sank early Friday.
Myovant Sciences Enters the Market in IPO
Myovant Sciences entered the market near the high end of its expected price range for its initial public offering.
Is Community Health Facing an Outright Implosion?
Community Health Systems is looking and acting like it is an implosion waiting to happen. The company has projected a loss for its third-quarter earnings report.
ProQR Jumps on Positive Phase 1 Results
Shares of ProQR Therapeutics jumped early on Thursday after the company announced results from its cystic fibrosis study.
What to Look For in Bristol-Myers Earnings
Bristol-Myers Squibb Co. (NYSE: BMY) is scheduled to release third-quarter financial results before markets open on Thursday. The consensus estimates from Thomson Reuters are calling for $0.65 in earnings per share (EPS) and $4.79…